April 16, 2026 12:43 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
‘We are surprised’: SC stays Pawan Khera’s bail over remarks on Himanta Biswa Sarma’s wife | Historic shift: Bihar gets first BJP CM as Samrat Choudhary takes oath | 'ECI deviated from Bihar procedure': Supreme Court raises concerns over voter deletion in Bengal SIR | Noida workers’ protest turns violent: Stones pelted, vehicles damaged over wage hike demand | Oil prices jump above $103 a barrel as US moves to block Iran-linked shipping | I don’t care if they come back or not, says Trump after Iran talks collapse | Legendary singer Asha Bhosle suffers cardiac arrest, hospitalised | Big boost to India–Mauritius ties: S. Jaishankar hands over 90 e-buses | Middle East tension: Iranian delegation arrives in Islamabad for major talks, 10,000 security personnel deployed | Ranveer Singh visits RSS HQ amid Dhurandhar 2 success, triggers speculation
COVID-19
Image Credit: UNI

India reports 60,471 new COVID-19 cases, 2,726 deaths in 24 hours

| @indiablooms | Jun 15, 2021, at 04:18 pm

New Delhi/IBNS: India on Tuesday reported less than one lakh new COVID-19 cases for the eighth consecutive days while the toll in the last 24 hours remained under the three-thousand-mark.

In the last 24 hours, the Asian country with a huge population added 60,471 new infections pushing the overall tally to 29,570,881.

With 2,726 deaths apparently linked to the virus caused in the same time span, the COVID-19 toll has peaked to 3,77,031.

The recovery figure has further improved to 2,82,80,472 with 1,17,525 COVID-19 patients testing negative for the virus.

Meanwhile, the All India Institute of Medical Sciences (AIIMS), New Delhi will begin the selection process of children in the age group of 6-12 years for the clinical trials of Bharat Biotech's Covaxin on Tuesday, said Dr Sanjay Rai, professor at the Centre for Community Medicine at AIIMS Delhi, said a media report.

After the recruitment of children in the age group is done, the process for clinical trials for children between 2 to 6 years of age will be started, the report added.

The screening for clinical trials in the age group of 12 to 18 is already completed and they have been administered with a single dose of the vaccine, it said.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.